Two 340B hospitals urged a federal district court to block drugmaker Johnson & Johnson (J&J) from conducting “unlawfully authorized” audits [...] …
Category: Providers
New Jersey-based drug manufacturing giant Merck and a large Wisconsin-based health system are the latest to join the 340B Working [...] …
Just days after a federal court in Mississippi denied Novartis’ attempt to block the state’s 340B contract pharmacy access law, [...] …
Health System Urges Federal Appeals Court to Revive 340B Overcharge Lawsuit Against Major Drugmakers
A California health system has urged a federal appeals court to reverse a lower court’s decision to dismiss its lawsuit [...] …
Merck will loosen its 340B contract pharmacy restrictions in Minnesota and Missouri, becoming the first drugmaker to officially update its [...] …
The Massachusetts Senate on Thursday failed to adopt legislation that would have prohibited pharmacy benefit managers (PBMs) from imposing discriminatory [...] …
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws this summer, [...] …
SK Life Science issued a refund notice for an epilepsy drug following a 340B price ceiling recalculation. Multiple drug manufacturers [...] …
Eligible providers in Texas can now immediately enroll in the 340B program without waiting for the normal quarterly registration period [...] …
Certain hospitals’ failure to pass 340B savings on to patients is a leading cause of medical debt, two Republican lawmakers [...] …